To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and UTMB collaborate to provide an annual training course on how to meet GLP requirements in BSL-4 facilities
Similar Posts
Early Alert: Blood Pump Controller Issue from Abiomed
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramSprout Organics Expands Voluntary Recall of Sweet Potato Apple and Spinach to Include Additional Lot Codes
Sprout Organics is expanding its September 16, 2025 recall of Sprout Organics® Sweet Potato Apple and Spinach, due to potentially elevated lead levels, to include additional lots.Daewoo Pharmaceutical Co., Ltd. – 706371 – 07/02/2025
CGMP/Finished Pharmaceuticals/AdulteratedBlendHouse LLC. Reading, PA. 483 issued 01/19/2024
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 01/19/2024
Short Title (70 char) BlendHouse LLC. Reading, PA. 483 issued 01/19/2024
FEI Number 3015728839
Firm Name BlendHouse LLC
Record Type 483
State PA
Establishment Type ManufacturerCDER Center for Clinical Trial Innovation (C3TI)
Enable and amplify existing and future CDER clinical trial innovation through enhanced communication and collaboration